MarketInOut Stock Screener Log In | Sign Up

20/20 Biolabs Inc

NASDAQ • Healthcare • Medical Devices • Quote as of 10/30/2026
20/20 Biolabs Inc stock price and volume chart

Company Profile

IndustryMedical Devices
SectorHealthcare
ExchangeNASDAQ
Market Capitalization2.96 mln
Float8.48 mln
Earnings Date11/30/2026

Relative Strength

8 / 100
Severely lagging

Debt / Equity

0.18
Very low leverage

Pre-Tax Margin

-285%
Severely loss-making

ROE

-387
Deeply negative

Altman Z-Score

-9.32
Deeply distressed

ROA

-120
Deeply negative

Business Description

20/20 GeneSystems is a Maryland-based medical testing company that helps detect cancer early through blood tests and provides tools to identify viral infections like COVID-19. Beyond direct testing, it runs a shared laboratory facility where new diagnostic companies can develop and launch their products in the U.S. market. It also works with healthcare providers to deliver its cancer screening technology through a software platform.

Key Fundamentals

EPS-0.75
ROE-387
RPS0.29
ROIC-179
ROA-120
Interest Cover-6.34
EBITDA, mln-5.05
EV / EBITDA-0.62
EV / EBIT-0.61
Revenue, mln2.04
EV / Revenue1.54

Quote Details

Last 0.213
Change -0.0155 (-6.78%)
Open 0.2252
Volume 246,684
Turnover 52,544
Average Volume 146,869

Financial Ratios

Pre-Tax Profit Margin-285
Leverage Ratio1.94
Current Ratio1.99
Price / Book3.35
Price / Tangible Book4.84
Debt / Equity0.18
Price / Sales2.35

Financial Strength

Altman Z-Score-9.32
Short Ratio0.81
Short % of Float0.42

Price Performance & Relative Strength

Period Price Performance Relative Strength
1 Week -9.44% 10 / 100   
1 Month -47.91% 4 / 100   
2 Months -52.69% 8 / 100   
6 Months -86.26% 3 / 100   



Disclaimer - Privacy Policy - Terms of Service - Cookies - FAQ - Affiliates - Blog